Literature DB >> 1478056

Immunosenescence.

M S Currie1.   

Abstract

The aging immune system, while showing little in the way of quantitative changes, demonstrates important functional changes, especially T-cell functions. In addition to increased susceptibility to some infections, there is an increased likelihood of autoantibody production, and the emergence of monoclonal antibodies and other lymphoproliferative disorders. The role of the immune system in degenerative processes, and susceptibility to malignant processes requires further investigation. Biotechnology is producing many new methods of modulating immune function, with ever increasing specificity. Thus the future holds great promise for overcoming the effects of immunosenescence.

Entities:  

Mesh:

Year:  1992        PMID: 1478056

Source DB:  PubMed          Journal:  Compr Ther        ISSN: 0098-8243


  4 in total

Review 1.  Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.

Authors:  Syed Rizvi; Samer Gawrieh
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

Review 2.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

Review 3.  Drug therapy in the management of type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 4.  Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.

Authors:  Albert J Czaja
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.